Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData
The global cell and gene therapy market is expected to reach $80 billion in 2029, with a high CAGR of 51.6 per cent between 2023…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cell and gene therapy
Avantor expands Life Sciences Innovation Center to address bioprocessing needs in protein science,…
Increased investment in bioprocessing infrastructure furthers biologics innovation and improved efficiencies in bioproduction